Breast Cancer Research and Treatment

, Volume 142, Issue 2, pp 445–453

Is there a role for routine screening MRI in women with LCIS?

  • Tari A. King
  • Shirin Muhsen
  • Sujata Patil
  • Starr Koslow
  • Sabine Oskar
  • Anna Park
  • Mary Morrogh
  • Rita A. Sakr
  • Monica Morrow
Brief Report


Women with lobular carcinoma in situ (LCIS) have an elevated breast cancer risk, yet the benefit of MRI screening is unclear. We examined cancer detection rates with mammography alone versus mammography plus MRI in this high-risk population. From a prospectively maintained, single-institution database, we identified 776 patients diagnosed with LCIS after the adoption of screening MRI in April 1999. In addition to annual mammography and breast exam, MRI was used at the discretion of the physician and patient. Kaplan–Meier methods and landmark analyses at 1, 2, and 3 years following LCIS diagnosis were performed to compare rates of cancer detection with or without MRI. MRI screening was performed in 455 (59 %) patients (median, 3/patient). Median time from LCIS diagnosis to first MRI was 9 months (range 0.3–137 months). Patients undergoing MRI were younger (p < 0.0001), premenopausal (p < 0.0001), and more likely to have ≥1 first-degree relative with breast cancer (p = 0.009). At a median follow-up of 58 months, 98/776 (13 %) patients developed cancer. The crude cancer detection rate in both screening groups was 13 %. MRI was not associated with earlier stage, smaller size, or node negativity. Landmark analyses at 1, 2, and 3 years after LCIS diagnosis failed to demonstrate increased cancer detection rates among women having MRI (p = 0.23, 0.26, and 0.13, respectively). Although a diagnosis of LCIS remains a significant risk factor for breast cancer, the routine use of MRI does not result in increased cancer detection rates (short-term), nor does it result in earlier stage at diagnosis, illustrating the importance of defining optimal screening strategies for high-risk patients based on tumor biology rather than numerical risk.


LCIS MRI Screening High risk Breast cancer 

Supplementary material

10549_2013_2725_MOESM1_ESM.eps (955 kb)
Supplemental File No. 1 Number of patients entered into the lobular carcinoma in situ (LCIS) surveillance database and use of MRI screening per year, April 1999 to December 2009


  1. 1.
    Haagensen CD, Lane N, Lattes R, Bodian C (1978) Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 42:737–769PubMedCrossRefGoogle Scholar
  2. 2.
    Page DL, Kidd TE Jr, Dupont WD, Simpson JF, Rogers LW (1991) Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 22:1232–1239PubMedCrossRefGoogle Scholar
  3. 3.
    Rosen PP, Kosloff C, Lieberman PH, Adair F, Braun DW Jr (1978) Lobular carcinoma in situ of the breast: detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol 2:225–251PubMedCrossRefGoogle Scholar
  4. 4.
    Chuba PJ, Hamre MR, Yap J, Severson RK, Lucas D, Shamsa F, Aref A (2005) Bilateral risk for subsequent breast cancer after lobular carcinoma-in situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol 23:5534–5541PubMedCrossRefGoogle Scholar
  5. 5.
    Saslow D, Boetes C, Burke W et al (2007) American cancer society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57:75–89PubMedCrossRefGoogle Scholar
  6. 6.
    Kriege M, Brekelmans CT, Boetes C et al (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351:427–437PubMedCrossRefGoogle Scholar
  7. 7.
    Kuhl CK, Schrading S, Leutner CC, Morakkabati-Spitz N, Wardelmann E, Fimmers R, Kuhn W, Schild HH (2005) Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23:8469–8476PubMedCrossRefGoogle Scholar
  8. 8.
    Lehman CD, Blume JD, Weatherall P et al (2005) Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 103:1898–1905PubMedCrossRefGoogle Scholar
  9. 9.
    Friedlander LC, Roth SO, Gavenonis SC (2011) Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ. Radiology 261:421–427PubMedCrossRefGoogle Scholar
  10. 10.
    Port ER, Park A, Borgen PI, Morris E, Montgomery LL (2007) Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia. Ann Surg Oncol 14:1051–1057PubMedCrossRefGoogle Scholar
  11. 11.
    Sung JS, Malak SF, Bajaj P, Alis R, Dershaw DD, Morris EA (2011) Screening breast MR imaging in women with a history of lobular carcinoma in situ. Radiology 261:414–420PubMedCrossRefGoogle Scholar
  12. 12.
    Kaas R, Muller SH, Hart AA, Rutgers EJ (2008) Stage of breast cancers found during the surveillance of women with a familial or hereditary risk. Eur J Surg Oncol 34:501–507PubMedCrossRefGoogle Scholar
  13. 13.
    Tilanus-Linthorst MM, Obdeijn IM, Hop WC, Causer PA, Leach MO, Warner E, Pointon L, Hill K, Klijn JG, Warren RM, Gilbert FJ (2007) BRCA1 mutation and young age predict fast breast cancer growth in the Dutch, United Kingdom, and Canadian magnetic resonance imaging screening trials. Clin Cancer Res 13:7357–7362PubMedCrossRefGoogle Scholar
  14. 14.
    King TA, Sakr RA, Muhsen S, Andrade VP, Giri D, Van Zee KJ, Morrow M (2012) Is there a low-grade precursor pathway in breast cancer? Ann Surg Oncol 19:1115–1121PubMedCrossRefGoogle Scholar
  15. 15.
    Fisher ER, Land SR, Fisher B, Mamounas E, Gilarski L, Wolmark N (2004) Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ. Cancer 100:238–244PubMedCrossRefGoogle Scholar
  16. 16.
    Mann RM, Hoogeveen YL, Blickman JG, Boetes C (2008) MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature. Breast Cancer Res Treat 107:1–14PubMedCrossRefGoogle Scholar
  17. 17.
    Gao X, Fisher SG, Emami B (2003) Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys 56:1038–1045PubMedCrossRefGoogle Scholar
  18. 18.
    Lehman CD (2006) Role of MRI in screening women at high risk for breast cancer. J Magn Reson Imaging 24:964–970PubMedCrossRefGoogle Scholar
  19. 19.
    Leach MO, Boggis CR, Dixon AK et al (2005) Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365:1769–1778PubMedCrossRefGoogle Scholar
  20. 20.
    Morris EA, Liberman L, Ballon DJ, Robson M, Abramson AF, Heerdt A, Dershaw DD (2003) MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol 181:619–626PubMedCrossRefGoogle Scholar
  21. 21.
    Heijnsdijk EA, Warner E, Gilbert FJ et al (2012) Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI Screening-MRISC, MARIBS, and Canadian studies combined. Cancer Epidemiol Biomarkers Prev 21:1458–1468PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Tari A. King
    • 1
  • Shirin Muhsen
    • 1
  • Sujata Patil
    • 2
  • Starr Koslow
    • 1
  • Sabine Oskar
    • 1
  • Anna Park
    • 1
  • Mary Morrogh
    • 1
  • Rita A. Sakr
    • 1
  • Monica Morrow
    • 1
  1. 1.Breast Service, Department of SurgeryMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  2. 2.Department of Epidemiology and BiostatisticsMemorial Sloan-Kettering Cancer CenterNew YorkUSA

Personalised recommendations